Table 1. Association between FBXO31 expression and clinicopathological variables of 90 gastric cancer cases.
| Clinicopathological parameters | n | FBXO31 expression | χ2 | P value | |
|---|---|---|---|---|---|
| positive | negative | ||||
| all | 90 | 43 | 47 | ||
| age(year) | 1.558 | 0.212 | |||
| <60 | 31 | 12 | 19 | ||
| ≥60 | 59 | 31 | 28 | ||
| gender | 0.03 | 0.863 | |||
| male | 62 | 30 | 32 | ||
| female | 28 | 13 | 15 | ||
| tumor size(cm) | 5.257 | 0.022* | |||
| ≤5 | 41 | 25 | 16 | ||
| >5 | 49 | 18 | 31 | ||
| Tumor infiltration | 7.442 | 0.024* | |||
| T1/T2 | 11 | 8 | 3 | ||
| T3 | 56 | 29 | 27 | ||
| T4 | 23 | 6 | 17 | ||
| Local lymph node metastasis | 6.87 | 0.076 | |||
| N0 | 25 | 14 | 11 | ||
| N1 | 10 | 8 | 2 | ||
| N2 | 26 | 10 | 16 | ||
| N3 | 29 | 11 | 18 | ||
| Distant metastasis | - | - | |||
| M0 | 89 | 42 | 47 | ||
| M1 | 1 | 1 | 0 | ||
| Grade | 8.828 | 0.012* | |||
| 1 | 16 | 13 | 3 | ||
| 2 | 63 | 26 | 37 | ||
| 3 | 11 | 4 | 7 | ||
n Numbers of cases in each group.
Statistically significant(P<0.05).